Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of SGLT2 Inhibitors on Coronary Atherosclerosis Progression in Diabetes Mediated by Perivascular Adipose Tissue: The SCOPE Trial

NCT07614230 is registered in ClinicalTrials.gov with Junjie Yang as lead sponsor.

NCT NCT07614230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07614230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of SGLT2 Inhibitors on Coronary Atherosclerosis Progression in Diabetes Mediated by Perivascular Adipose Tissue: The SCOPE Trial
Lead sponsor
Junjie Yang
Phase
Phase 4
Overall status
Recruiting
Start date
January 1, 2026
Completion date
December 31, 2028
Enrollment
144 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary artery disease, type 2 diabetes mellitus (t2dm)